Av&R

Av&R company information, Employees & Contact Information

Explore related pages

Related company profiles:

At AV&R, we propel manufacturing into the future by delivering cutting-edge robotic finishing and inspection machines. We are a Canadian company with over 30 years of expertise in robotics and automation, operating worldwide and collaborating with major OEMs worldwide. As a leader in robotic finishing & inspection machines, we specialize in automating manufacturing processes for the aerospace and medical industries. Our innovative solutions improve precision, efficiency, and quality, helping clients optimize production and meet the highest industry standards.
Looking for a particular Av&R employee's phone or email?

Av&r Questions

News

Anteris successfully treats first patients in global DurAVR pivotal trial - Proactive financial news

Anteris successfully treats first patients in global DurAVR pivotal trial Proactive financial news

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) - GlobeNewswire

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) GlobeNewswire

Anteris Technologies Global Corp Enrolls First Patients in PARADIGM Trial - TradingView

Anteris Technologies Global Corp Enrolls First Patients in PARADIGM Trial TradingView

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) - Stock Titan

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) Stock Titan

Anteris Tech (ASX:AVR) Hits Milestone in DurAVR Trial - Kalkine Media

Anteris Tech (ASX:AVR) Hits Milestone in DurAVR Trial Kalkine Media

Anteris Technologies Global (ASX:AVR) Will Have To Spend Its Cash Wisely - Yahoo Finance

Anteris Technologies Global (ASX:AVR) Will Have To Spend Its Cash Wisely Yahoo Finance

Anteris Technologies Global shareholders approve ASX waiver, provide trial update - Investing.com

Anteris Technologies Global shareholders approve ASX waiver, provide trial update Investing.com

ST-Segment Depression in aVR: An Overlooked Finding Associated With an Anterior Infarction - JACC Journals

ST-Segment Depression in aVR: An Overlooked Finding Associated With an Anterior Infarction JACC Journals

Anteris Technologies secures Danish clearance for global PARADIGM trial of DurAVR® Valve - Proactive financial news

Anteris Technologies secures Danish clearance for global PARADIGM trial of DurAVR® Valve Proactive financial news

Anteris (AVR) Welcomes Two Directors as Major Trial Approaches - Insider Monkey

Anteris (AVR) Welcomes Two Directors as Major Trial Approaches Insider Monkey

Anteris Receives First European Regulatory Clearance to - GlobeNewswire

Anteris Receives First European Regulatory Clearance to GlobeNewswire

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025 - The Manila Times

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025 The Manila Times

Anteris Technologies Global Corp. Rings the Opening Bell - Nasdaq

Anteris Technologies Global Corp. Rings the Opening Bell Nasdaq

Job Offers - FreshPlaza

Job Offers FreshPlaza

Institutions own 23% of Anteris Technologies Global Corp. (ASX:AVR) shares but retail investors control 54% of the company - Yahoo Finance

Institutions own 23% of Anteris Technologies Global Corp. (ASX:AVR) shares but retail investors control 54% of the company Yahoo Finance

Special Stockholder Meeting Delayed: Anteris Technologies Extends Voting Window for Critical Proposals - Stock Titan

Special Stockholder Meeting Delayed: Anteris Technologies Extends Voting Window for Critical Proposals Stock Titan

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders - GlobeNewswire

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders GlobeNewswire

Anteris reports second quarter 2025 results and clinical progress - Proactive financial news

Anteris reports second quarter 2025 results and clinical progress Proactive financial news

Anteris Announces Results for the First Quarter of 2025 - GlobeNewswire

Anteris Announces Results for the First Quarter of 2025 GlobeNewswire

Can Anteris Technologies Global (ASX:AVR) Afford To Invest In Growth? - simplywall.st

Can Anteris Technologies Global (ASX:AVR) Afford To Invest In Growth? simplywall.st

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering - Business Wire

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering Business Wire

AVR IPO News - Australian medical device company Anteris Technologies Global files for a $75 million US IPO - renaissancecapital.com

AVR IPO News - Australian medical device company Anteris Technologies Global files for a $75 million US IPO renaissancecapital.com

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering - Business Wire

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering Business Wire

Anteris Technologies Targets $75 Million US IPO (Pending:AVR) - Seeking Alpha

Anteris Technologies Targets $75 Million US IPO (Pending:AVR) Seeking Alpha

News: Simplify Manufacturer’s Lives With Industry 5.0 | AV&R - A3 Association for Advancing Automation

News: Simplify Manufacturer’s Lives With Industry 5.0 | AV&R A3 Association for Advancing Automation

AVR Swarna Mahal all set to launch D.REN, its new high jewellery brand with global ambition - The Retail Jeweller India

AVR Swarna Mahal all set to launch D.REN, its new high jewellery brand with global ambition The Retail Jeweller India

4 questions on finishing automation - Canadian Metalworking

4 questions on finishing automation Canadian Metalworking

Anteris re-domiciliation finalised: shares trading on ASX and Nasdaq - Proactive financial news

Anteris re-domiciliation finalised: shares trading on ASX and Nasdaq Proactive financial news

ST-Segment Elevation in Lead aVR With Global ST-Segment Depression: Never Neglect Left Main Coronary Artery (LMCA) Occlusion - Cureus

ST-Segment Elevation in Lead aVR With Global ST-Segment Depression: Never Neglect Left Main Coronary Artery (LMCA) Occlusion Cureus

Anteris Announces Results for the Second Quarter of 2025 - Yahoo Finance

Anteris Announces Results for the Second Quarter of 2025 Yahoo Finance

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - Yahoo Finance

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors Yahoo Finance

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV GlobeNewswire

Anteris Technologies Begins Global PARADIGM Trial Enrollment - TipRanks

Anteris Technologies Begins Global PARADIGM Trial Enrollment TipRanks

Anteris secures first European green light to start PARADIGM pivotal trial of DurAVR THV - Proactive financial news

Anteris secures first European green light to start PARADIGM pivotal trial of DurAVR THV Proactive financial news

Irish company CWSI acquires AVR International for €5.2m - Silicon Republic

Irish company CWSI acquires AVR International for €5.2m Silicon Republic

Clinical outcomes after implantation of a sutureless aortic bioprosthesis with concomitant mitral valve surgery: the SURE-AVR registry - Journal of Cardiothoracic Surgery

Clinical outcomes after implantation of a sutureless aortic bioprosthesis with concomitant mitral valve surgery: the SURE-AVR registry Journal of Cardiothoracic Surgery

Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient: A State-of-the-Art Review - ScienceDirect.com

Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient: A State-of-the-Art Review ScienceDirect.com

Anteris Technologies Global completes $11.5 million common stock offering - Investing.com

Anteris Technologies Global completes $11.5 million common stock offering Investing.com

Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV - Proactive financial news

Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV Proactive financial news

Anteris Technologies Announces First Successful Implantation of DurAVR THV in a Valve-in-Valve Procedure - HMP Global Learning Network

Anteris Technologies Announces First Successful Implantation of DurAVR THV in a Valve-in-Valve Procedure HMP Global Learning Network

Technical Deep Dive: Cities and Climate Change - World Bank Group

Technical Deep Dive: Cities and Climate Change World Bank Group

WMW | WtE and Carbon Capture: 10+1 things to know about CCUS and Waste-to-Energy - Waste Management World

WMW | WtE and Carbon Capture: 10+1 things to know about CCUS and Waste-to-Energy Waste Management World

Denon AVR-X8500H World's First 13.2CH AV Receiver Preview - audioholics.com

Denon AVR-X8500H World's First 13.2CH AV Receiver Preview audioholics.com

Greenhouse Helps Dutch Waste to Energy Facility Cut CO2 Emissions by 15% - Waste Management World

Greenhouse Helps Dutch Waste to Energy Facility Cut CO2 Emissions by 15% Waste Management World

Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve - Proactive financial news

Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve Proactive financial news

UK’s Customs Valuation Ruling System is Live - Global Compliance News

UK’s Customs Valuation Ruling System is Live Global Compliance News

Voltage Regulation - Siemens

Voltage Regulation Siemens

Anteris Technologies changes name from Admedus Ltd following shareholder approval - Proactive financial news

Anteris Technologies changes name from Admedus Ltd following shareholder approval Proactive financial news

Anteris Technologies Announces A$38.5 Million Private Placement - Sharecafe

Anteris Technologies Announces A$38.5 Million Private Placement Sharecafe

Significance of lead aVR in acute coronary syndrome - Baishideng Publishing Group

Significance of lead aVR in acute coronary syndrome Baishideng Publishing Group

Smart Surround by Denon: The HEOS AVR - v2com newswire

Smart Surround by Denon: The HEOS AVR v2com newswire

Diagnosing total left main obstruction on ECG, is the role of lead avR "overhyped" ? - Medical Dialogues

Diagnosing total left main obstruction on ECG, is the role of lead avR "overhyped" ? Medical Dialogues

Anteris Technologies is leading a heart condition treatment revolution - Stockhead

Anteris Technologies is leading a heart condition treatment revolution Stockhead

New Denon Receivers - AVR-2105, AVR-5805, AVR-2805, AVR-1905, and AVR-1705 - audioholics.com

New Denon Receivers - AVR-2105, AVR-5805, AVR-2805, AVR-1905, and AVR-1705 audioholics.com

Top Av&R Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant